Submission of Financial Result Quarter Ended 30TH June 2025. (FY26)

Revenue Growth 20pctPat Growth 25pctResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.9%Reaction day

₹128.75

prior close

₹135.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.8%+2.8% vs market

Hospital peers, median of 20sector-0.8%+2.7% vs sector

On the reaction day the stock moved 2.8 pts more than Nifty Microcap 250 and 2.7 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.9-0.8+2.8-0.8+2.7

Next day

+1.0-0.7+1.6-0.0+1.0

+1.0-0.6+1.6+0.9+0.0

-2.1+0.0-2.2+2.3-4.5

-2.9-0.8-2.1+1.6-4.5

-0.6+0.7-1.3+1.8-2.4

-2.1+1.9-4.0+2.4-4.5

15d

-3.0+0.9-3.9-0.0-3.0

+5.9+1.7+4.2+0.3+5.6

+1.0+0.2+0.8+4.3-3.4

+12.6+0.8+11.8+2.0+10.6

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 20Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Asarfi Hospital reported strong Q1 FY26 results with revenue from operations rising to ₹35.66 crore, up about 55.6% from ₹22.92 crore in Q1 FY25. Total income grew to ₹37.08 crore from ₹23.60 crore, a jump of nearly 57%. Profit after tax more than doubled to ₹3.20 crore on a standalone basis (₹3.12 crore consolidated), compared to ₹1.53 crore (₹1.45 crore consolidated) in the same quarter last year. EPS rose to ₹1.62 (standalone) and ₹1.59 (consolidated) from ₹0.78 and ₹0.74 respectively. The board also approved a sanctioned loan of ₹8.25 crore from HDFC Bank — ₹5.25 crore term loan for building an educational facility and ₹3 crore working capital for the Asarfi Cancer Unit. The statutory auditor issued a clean limited review report with no qualifications.

Likely market impact

Strong double-digit revenue and profit growth signals healthy operational expansion of the hospital business. The fresh HDFC Bank funding supports upcoming capacity expansion, which could drive future earnings but will also increase the debt load — shareholders should watch for execution of these projects.